Economic Burden of Melanoma in the Elderly Population
- 1 March 2010
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 146 (3), 249-256
- https://doi.org/10.1001/archdermatol.2009.389
Abstract
Objective To assess health care resources consumed by melanoma in the population 65 years or older, a group with comparatively poor outcomes. Design Database analysis. Setting The Surveillance, Epidemiology, and End Results (SEER)–Medicare-linked population-based database for fiscal years 1991 through 1996. Participants A total of 1858 subjects with pathological confirmation of melanoma. Main Outcome Measures Resource consumption was examined by stage and treatment phase. Outcomes were measured in monthly charges obtained from the data set and costs were estimated by application of cost to charge ratios. Annual resource consumption by melanoma in patients 65 years or older in the United States was also estimated by incorporation of published SEER cancer statistics. Results Average monthly, per-patient melanoma charges were $2194 during the initial 4 months of treatment; they dropped by more than half to $902 during the interim phase, which varied in length depending on survival. Monthly charges increased to $3933 during the terminal 6 months of treatment. The estimated annual charge of treating melanoma in the population 65 years or older was $390 million. By using cost to charge ratios, we found the annual cost of melanoma to be up to $249 million and the per-patient lifetime costs to be $28 210 from the time of diagnosis to the time of death. Conclusions Melanoma care presents a significant economic burden in the elderly population, particularly in late-stage disease. If effective, prevention and early detection efforts may reduce the economic burden.Keywords
This publication has 12 references indexed in Scilit:
- A Call for the Development and Implementation of a Targeted National Melanoma Screening ProgramArchives of Dermatology, 2006
- Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000Journal of Clinical Oncology, 2004
- Ultraviolet Carcinogenesis in Nonmelanoma Skin Cancer Part II: Review and Update on Epidemiologic CorrelationsSKINmed: Dermatology for the Clinician, 2004
- Melanoma Incidence and Mortality Among US Whites, 1969-1999JAMA, 2002
- Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.Published by Rockefeller University Press ,2002
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Laboratory tests and imaging studies in patients with cutaneous malignant melanomaJournal of the American Academy of Dermatology, 1998
- An estimate of the annual direct cost of treating cutaneous melanomaJournal of the American Academy of Dermatology, 1998
- The multidisciplinary melanoma clinic: A cost outcomes analysis of specialty careJournal of the American Academy of Dermatology, 1998
- Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at DiagnosisMedical Care, 1995